BioNTech SE Stock Earns Membership In 95-Plus Composite Rating Club

BioNTech SE Stock Earns Membership In 95-Plus Composite Rating Club
·2 min read

The IBD SmartSelect Composite Rating for BioNTech SE Ads rose from 94 to 97 Thursday. The Covid-19 vaccine stock also has 98 Relative Strength Rating. BioNTech SE stock has now climbed above a proper buy zone after breaking out from a 131.10 buy point in a consolidation.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting